N-1403 | Neurotensin (1-8) | C46H71N13O14 | 1030.15 | 80887-44-1 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-OH |
N-1404 | Neurotensin (1-11) | C66H99N19O18 | 1446.63 | 74032-89-6 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-OH |
N-1405 | Neurotensin (8-13) | C38H64N12O8 | 817.00 | 60482-95-3 | H-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
N-1405-2 | Acetyl-Neurotensin (8-13) | C40H66N12O9 | 859.04 | 74853-69-3 | Ac-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
N-1405-3 | (Dab9)-Neurotensin (8-13) | C36H60N10O8 | 760.94 | 166824-25-5 | H-Arg-Dab-Pro-Tyr-Ile-Leu-OH |
N-1405-5 | (Lys8,Lys9)-Neurotensin (8-13) | C38H64N8O8 | 760.98 | 139026-64-5 | H-Lys-Lys-Pro-Tyr-Ile-Leu-OH |
N-1405-6 | (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | C39H59N11O8 | 809.97 | 160662-16-8 | Cyclo(-Arg-Lys-Pro-Trp-Glu)-Leu-OH |
N-1406 | Neurotensin (9-13) | C32H52N8O7 | 660.81 | 60482-96-4 | H-Arg-Pro-Tyr-Ile-Leu-OH |
N-1501 | Brain Injury Derived Neurotrophic Peptide BINP |
C62H102N18O18 | 1387.60 | 148330-12-5 | H-Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 |
N-1502 | Neurotrophic Factor for Retinal Cholinergic Neurons | C53H84N12O16 | 1145.32 | 156707-52-7 | H-Tyr-Leu-Leu-Pro-Ala-Gln-Val-Asn-Ile-Asp-OH Trifluoroacetate salt |
N-1503 | Prepro-Nerve Growth Factor (99-115) (mouse) | C89H139N27O26 | 2003.25 | H-Pro-Glu-Ala-His-Trp-Thr-Lys-Leu-Gln-His-Ser-Leu-Asp-Thr-Ala-Leu-Arg-OH | |
N-1601 | Nociceptin, Orphanin FQ | C79H129N27O22 | 1809.06 | 170713-75-4 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH Trifluoroacetate salt |
N-1602 | Nociceptin (1-13) amide Orphanin FQ (1-13) amide |
C61H100N22O15 | 1381.60 | 178064-02-3 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 Trifluoroacetate salt |
N-1603 | C44H70N14O9 | 939.13 | 200959-48-4 | Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | |
N-1604 | C22H26N4O5 | 426.47 | 40204-87-3 | H-Phe-Gly-Gly-Phe-OH | |
O-0101 | Obestatin (human) | C116H176N32O33 | 2546.87 | 1081110-72-6 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 |
O-0101-2 | Biotinyl-Obestatin (human) | C126H190N34O35S | 2773.17 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 | |
O-0102 | Obestatin (rat) | C114H174N34O31 | 2516.85 | 869705-22-6 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 |
O-0102-2 | Biotinyl-Obestatin (rat) | C124H188N36O33S | 2743.15 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 | |
O-0201 | DOTA-(Tyr3)-Octreotate DOTATATE, DOTA-(Tyr3,Thr8)-Octreotide |
C65H90N14O19S2 | 1435.65 | 177943-89-4 | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (Disulfide bond) |